Jeffrey Hausdorff to Paclitaxel
This is a "connection" page, showing publications Jeffrey Hausdorff has written about Paclitaxel.
Connection Strength
0.012
-
A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance. Clin Cancer Res. 2001 May; 7(5):1221-9.
Score: 0.012
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.